← Back to Search

RECELL for Carbon Dioxide Laser Recovery

Phase 4
Recruiting
Led By Joseph Molnar, MD, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients undergoing facelift with perioral CO2 laser treatment
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 3
Awards & highlights

Study Summary

This trial will test whether using a person's own cells to treat side effects of CO2 laser treatment can reduce healing time.

Who is the study for?
This trial is for adults over 18 with a light skin tone (Fitzpatrick Score 1 or 2) who are getting a facelift and CO2 laser treatment around the mouth. It's not for those who've had perioral CO2 laser resurfacing before or have allergies to the ReCell system components.Check my eligibility
What is being tested?
The study tests if using ReCell, which involves applying your own cells after they're prepared through special processes, can reduce side effects from CO2 laser treatments and speed up healing of the skin.See study design
What are the potential side effects?
While specific side effects aren't listed, generally procedures like this could cause redness, swelling, sensitivity at the application site, infection risk or an allergic reaction to the preparation used.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am getting a facelift and CO2 laser treatment around my mouth.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 3
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 3 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in FACE-Q scale scores
Change in Skin sensitivity scores - burning
Change in Skin sensitivity scores - itching
+4 more
Secondary outcome measures
Healing within 2 weeks post-op

Trial Design

2Treatment groups
Experimental Treatment
Group I: Right receives ReCell (A)Experimental Treatment1 Intervention
Right perioral area of face receives ReCell/ Left receives saline
Group II: Left receives ReCell (B)Experimental Treatment1 Intervention
Left perioral area of face receives ReCell/ Right receives saline
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ReCell
2015
Completed Phase 4
~30

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,244 Previous Clinical Trials
1,004,778 Total Patients Enrolled
Avita MedicalIndustry Sponsor
15 Previous Clinical Trials
640 Total Patients Enrolled
Joseph Molnar, MD, PhDPrincipal InvestigatorWake Forest University Health Sciences
2 Previous Clinical Trials
17 Total Patients Enrolled

Media Library

Left receives ReCell (B) Clinical Trial Eligibility Overview. Trial Name: NCT05386368 — Phase 4
Carbon Dioxide Laser Research Study Groups: Left receives ReCell (B), Right receives ReCell (A)
Carbon Dioxide Laser Clinical Trial 2023: Left receives ReCell (B) Highlights & Side Effects. Trial Name: NCT05386368 — Phase 4
Left receives ReCell (B) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05386368 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this scientific experiment still enrolling participants?

"Visiting clinicaltrials.gov, we can confirm that this study is not accepting new participants at present, as the last update to it occurred on November 27th 2022. Despite its lack of recruitment activity, there are currently 6 other medical studies looking for patients right now."

Answered by AI

Are elderly individuals being included in the recruitment process of this research?

"Eligible participants for this medical research must be aged 18 or older but no more than 99 years old."

Answered by AI

To what extent might this treatment be hazardous to those engaging in it?

"The safety of this particular therapeutic intervention is deemed as level 3 due to it being a Phase 4 trial, indicating the approval and extensive clinical research that has already been conducted."

Answered by AI

Who qualifies to partake in this investigation?

"This trial is aiming to accept 10 participants, ranging from 18 years of age to 99. The key inclusion criteria for enrolment include: adults aged over 18; Fitzpatrick Score 1 or 2 skin type; and a current carbon dioxide laser treatment related facelift procedure."

Answered by AI
~6 spots leftby Dec 2025